Cellply
PrivateLast Round
VC Round
Apr 23, 2026
Total Funding Raised
$8.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellply is a biotechnology company that develops analytical tools and platforms for the characterization of cancer immunotherapies and cell therapies at single-cell resolution.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellply Comparables
Compare Cellply with similar companies based on industry and business-model similarity.
Cellply Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2026 | ||||
| VC Round | Sep 27, 2023 | ||||
| VC Round | Dec 14, 2021 | ||||
| Grant | Aug 2, 2018 | ||||
| Grant | May 1, 2018 | ||||
Grant | Oct 20, 2016 |
Key People
Founding team and executive leadership
Cellply Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ZernikeMeta Ventures | Seed |
| Meta Ventures | VC Round |
| European Commission | Grant |
| Indaco Venture Partners SGR | VC Round |
| Rearden | VC Round |
| CDP Venture Capital SGR | VC Round |
| LIFTT EuroInvest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 8504% MoM, from 46 to 4K.
- Apr 23, 2026
$8.4M raised with ENEA-Tech and CDP Venture Capital.
Cellply Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cellply's valuation, stock price, and market status.
Is Cellply a public or private company?
Cellply is a private company.
What is the current stock price of Cellply?
Cellply is a private company with no public stock price. No recent secondary market data is available.
How much is Cellply worth (valuation)?
Valuation information for Cellply is not publicly available.
Can I buy Cellply stock?
Cellply shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cellply's last funding round?
Cellply's most recent funding round was Early Funding on May 11, 2026.
Who are the main investors in Cellply?
Key investors in Cellply include European Commission, LIFTT EuroInvest, ENEA-Tech and Biomedical Foundation.
Will Cellply IPO soon?
No public IPO plans have been announced for Cellply.
How can I track Cellply secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellply's secondary market activity and sign up for updates.